Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aytu Biopharma Inc
(NQ:
AYTU
)
1.570
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EST, Dec 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aytu Biopharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Aytu BioPharma's Earnings: A Preview
November 13, 2023
Via
Benzinga
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year
November 08, 2023
Via
ACCESSWIRE
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
November 07, 2023
Via
ACCESSWIRE
Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard
November 06, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022 and remained a focus of traders looking for the next big move. High short interest and steep borrowing costs are among the...
Via
Benzinga
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
October 26, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
October 09, 2023
Via
ACCESSWIRE
Aytu BioPharma Inc. (NASDAQ: AYTU) Near the Top of Equities by Percentage Gain on 9/28
September 28, 2023
Via
Investor Brand Network
Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
September 26, 2023
Via
ACCESSWIRE
Earnings Outlook For Aytu BioPharma
September 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 28, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market
June 13, 2023
Via
ACCESSWIRE
Aytu BioPharma: Q3 Earnings Insights
May 11, 2023
Via
Benzinga
A Preview Of Aytu BioPharma's Earnings
May 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 27, 2023
Via
Benzinga
Earnings Scheduled For September 27, 2023
September 27, 2023
Companies Reporting Before The Bell • Paychex (NASDAQ:PAYX) is projected to report quarterly earnings at $1.12 per share on revenue of $1.29 billion.
Via
Benzinga
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
September 21, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at LD Micro Main Event XVI Conference
September 13, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
Via
Benzinga
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
August 08, 2023
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...
Via
Newsfile
Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority
July 31, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
July 10, 2023
Via
ACCESSWIRE
Star Equity Holdings And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
June 16, 2023
The Dow Jones closed higher by over 400 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Aytu to Participate in the Maxim Group Virtual Healthcare Conference
June 14, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
June 09, 2023
Via
ACCESSWIRE
AYTU Stock Earnings: Aytu Misses EPS, Revenue Estimates
May 11, 2023
AYTU stock earnings show Aytu Biopharma missing earnings per share and revenue estimates for the fiscal third quarter.
Via
InvestorPlace
Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results
May 11, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.